ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-38 Cr | ₹-42 Cr | ₹-21 Cr | ₹-21 Cr | ₹-16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-38 Cr |
| Mar2025 | ₹-42 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-16 Cr |
How is Deferred Tax Assets / Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-38 Cr | Negative | |
| Mar2025 | ₹-42 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹19,764.3 Cr | -2.3% | -3.4% | -10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -2.3% |
-3.4% |
-10.3% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses